The deal secures two sleep disorder drugs that would fill a hole in the company’s portfolio and intensify a competition with ...

Eli Lilly has gone big in the name of neuroscience, paying $6.3 billion in a front-loaded deal for Centessa Pharmaceuticals ...

An AI-powered algorithm could facilitate the diagnosis of a common sleep disorder that affects over 80 million people globally, suggests a new study published in the Annals of Neurology. REM sleep ...

Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult ...

Eli Lilly and Company (NYSE: LLY) and Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new ...

The involving Centessa Pharmaceuticals marks a notable step in expanding therapeutic reach into neuroscience. This move ...

Eli Lilly agreed to buy Centessa Pharmaceuticals in a deal valued at about $6.3 billion upfront, with total consideration ...

Eli Lilly (NYSE:LLY) has received U.S. FDA approval for Foundayo, the first once daily oral GLP 1 pill for obesity, and has ...

By Sneha S K March 31 (Reuters) - Eli Lilly said on Tuesday it would buy Centessa Pharmaceuticals in a deal valued at up to ...

Electroencephalography, or EEG, was invented 100 years ago. In the years since the invention of this device to monitor brain electricity, it has had an incredible impact on how scientists study the ...

How does the brain clean itself during sleep? A new ultrafast MRI method tracks cerebrospinal fluid flow without contrast ...

INDIANAPOLIS — Eli Lilly is acquiring United Kingdom-based company Centessa Pharmaceuticals for up to $7.8 billion. Lilly’s ...